Multiple roles of HDAC inhibition in neurodegenerative conditions.
about
Spinal muscular atrophySirtuins: molecular traffic lights in the crossroad of oxidative stress, chromatin remodeling, and transcriptionMicrobiota and Neurological Disorders: A Gut Feeling.Histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)-mediated correction of α1-antitrypsin deficiencyTherapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderSmall molecule inhibitors of zinc-dependent histone deacetylasesTransglutaminase is a therapeutic target for oxidative stress, excitotoxicity and stroke: a new epigenetic kid on the CNS blockGrowing the growth cone: remodeling the cytoskeleton to promote axon regenerationCreating a "Prosurvival Phenotype" Through Histone Deacetylase Inhibition: Past, Present, and FutureTherapeutic neuroprotective agents for amyotrophic lateral sclerosisThe interplay between microRNAs and histone deacetylases in neurological diseasesHuntington's disease: underlying molecular mechanisms and emerging conceptsHistone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell ViabilityTargeting histone deacetylases: perspectives for epigenetic-based therapy in cardio-cerebrovascular diseaseActivated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: restoring effects of inhibitors of HDACs, p38 MAPK and GSK3βRole of early life exposure and environment on neurodegeneration: implications on brain disordersHistone deacetylase inhibition decreases cholesterol levels in neuronal cells by modulating key genes in cholesterol synthesis, uptake and effluxSilencing of Fem1cR3 gene expression in the DBA/2J mouse precedes retinal ganglion cell death and is associated with histone deacetylase activityInduction of DARPP-32 by brain-derived neurotrophic factor in striatal neurons in vitro is modified by histone deacetylase inhibitors and Nab2The mood stabilizers valproic acid and lithium enhance mesenchymal stem cell migration via distinct mechanismsIn cortical neurons HDAC3 activity suppresses RD4-dependent SMRT exportFGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizersHistone deacetylase inhibition alters histone methylation associated with heat shock protein 70 promoter modifications in astrocytes and neuronsEpigenetic modulation of neuronal apoptosis and cognitive functions in sepsis-associated encephalopathyHistone deacetylase 6 gates the synaptic action of acute stress in prefrontal cortexHDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytesYin Yang 1 is a repressor of glutamate transporter EAAT2, and it mediates manganese-induced decrease of EAAT2 expression in astrocytesIdentification of HDAC Inhibitors Using a Cell-Based HDAC I/II AssayGeneral Anesthesia Causes Epigenetic Histone Modulation of c-Fos and Brain-derived Neurotrophic Factor, Target Genes Important for Neuronal Development in the Immature Rat Hippocampus.Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophyRole of histone deacetylase activity in the developing lateral line neuromast of zebrafish larvae.Protective effects of butyrate-based compounds on a mouse model for spinal muscular atrophy.Comparative modeling and benchmarking data sets for human histone deacetylases and sirtuin families.What's New in Traumatic Brain Injury: Update on Tracking, Monitoring and TreatmentEpigenetics: an expanding new piece of the stroke puzzleMechanisms of age-related cognitive change and targets for intervention: epigenetics.Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models.4-phenylbutyrate Mitigates Fluoride-Induced Cytotoxicity in ALC Cells.Epigenetics and the environment: in search of the "toleroasome" vital to execution of ischemic preconditioning.HDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammation
P2860
Q21202863-AA6EBFB9-AF61-4F6F-A4CE-68C1A64818EAQ21296795-8FFBE0FB-E0B4-4A60-9532-18BC4EAF6D1DQ24570085-6D1F7345-3E03-47CF-BE46-118E1F3D4561Q24619820-B8593AEC-AD28-4C57-9DAE-9AF3F59C9285Q24626017-647C6ADF-D1DC-4FBF-B8F9-A2E3146FA10EQ26824515-85BC2451-FB57-4A27-9509-FC956CDD8187Q26824549-721BC40C-72A0-49C8-97BB-55013C1C188AQ26829489-ABCEFCDF-70BA-47D3-B3CD-618A722BBD49Q26860240-63367DDC-3645-4545-9702-F83B5F474CF4Q27015029-AA3C84CC-91FB-43BD-9B57-11BD1F3C9528Q27024466-4AD03F13-80B1-476E-8E9E-9D8CB40A1FE1Q27026255-CA64C833-CBD7-4212-9E5A-9D09EFE1172DQ27679266-E2AF64AD-AB51-4C3A-AA68-F7839A42C6F1Q28085588-3A3FD0C4-783D-4A8F-9A21-AA98355DEA17Q28383951-1F3DC891-12DE-4DAD-9329-9C125853A9F5Q28386323-750FFD90-D216-4DDB-B40F-8FFE793DF680Q28484950-12AFF2B8-AC8A-41BF-BA86-7DBA118AA56FQ28506707-70D418AA-D7AC-404B-B44D-B52EF497C1BBQ28534553-4A7DAC1A-D7D7-4DD4-BAF5-FEE61087FD26Q28568768-9A77D34B-518D-4384-9960-8BFECE89C0ACQ28568860-026FC0D5-7B95-4591-804D-EF5CD820D230Q28570740-0740C222-8C3D-4B80-8F2F-CFFE7450A357Q28571794-D7D5331E-67B1-4BC1-B061-776EDFE1F873Q28572523-68514FD1-4792-48C1-9FB8-DA00D479E1B6Q28574489-2CCFACDA-BDF3-4FCC-A72A-1116A9BDD172Q28575023-D4AB459F-5522-4789-89F2-949789548472Q28583893-D641BADA-70BC-453E-94B2-F26A54CB01B0Q28829359-762D3EEF-FAEC-4EDE-BE16-FE715EED901FQ30277072-43EB9964-F7AD-499C-AE82-AC420C49326FQ30511954-CDDE21CD-534A-4C3E-8B83-9B1A97E41C11Q30575262-D18795CA-F898-44E2-A4D6-C08822029600Q30743508-C6600666-14B0-417F-A112-AF0737F47E64Q30886620-5F02D51D-4438-4803-AEE2-66F5430DE312Q30959630-84E64C98-60E3-46E4-B6DA-5F45341A75CEQ33352309-03707913-B075-4366-8C3A-89122834871FQ33565018-28DB4E98-DB38-4F39-A0C6-5B91817A3979Q33566724-D8013BE8-8E5A-46B7-9A11-8B02BF6CE89DQ33659019-6B9214B5-667E-43AC-89E4-30DE2E2B341DQ33693885-BD4E51EE-A517-4EC1-8430-52FF8A81C034Q33757971-45DC0CF8-AACA-41B3-9EF0-48C1CA7C9A54
P2860
Multiple roles of HDAC inhibition in neurodegenerative conditions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multiple roles of HDAC inhibition in neurodegenerative conditions.
@en
Multiple roles of HDAC inhibition in neurodegenerative conditions.
@nl
type
label
Multiple roles of HDAC inhibition in neurodegenerative conditions.
@en
Multiple roles of HDAC inhibition in neurodegenerative conditions.
@nl
prefLabel
Multiple roles of HDAC inhibition in neurodegenerative conditions.
@en
Multiple roles of HDAC inhibition in neurodegenerative conditions.
@nl
P2093
P2860
P1476
Multiple roles of HDAC inhibition in neurodegenerative conditions
@en
P2093
Chi-Tso Chiu
De-Maw Chuang
Hyeon-Ju Kim
P2860
P304
P356
10.1016/J.TINS.2009.06.002
P577
2009-09-21T00:00:00Z